Article
First report of a carbapenemase OXA-48 producing-Hafnia alvei clinical isolate.
2023-01-26
Abstract excerpt
<h4>Introduction: </h4> Carbapenems are usually used in the treatment of infections caused by cephalosporin-resistant Enterobacterales; however, the increase in carbapenem-resistant enterobacterales (CRE) has become one of the most important problems in public health. Hafnia alvei is associated with intestinal and extraintestinal infections, especially in patients with any chronic disease or some type of inmunosu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 892f8ec9-680b-5390-8129-394714e6cc7e
- DOI
- 10.1099/acmi.0.000498.v2
